Describe cardio-renal-metabolic (CRM) conditions and their impact on health and patient-centered outcomes. Recognize current gaps in screening, risk factor management, and utilization of guideline-directed therapies in patients with CRM conditions. Select appropriate guideline-directed therapies for patients with type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease based on current guidelines and clinical evidence. Recognize the importance of multidisciplinary care when managing patients with CRM conditions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12788/jfp.0622 | DOI Listing |
Publication Analysis
Top Keywords
crm conditions
16
cardio-renal-metabolic crm
8
guideline-directed therapies
8
therapies patients
8
patients crm
8
optimized management
4
management cardio-renal-metabolic
4
crm
4
conditions
4
patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!